What does it mean when we say that male BV treatment is "off-label"?

While this treatment is not yet recognized as standard care, Wisp has chosen to offer this treatment option, as prescribed by your provider based on his or her clinical judgment, based on the potential benefits of Metronidazole and Clindamycin in patients assigned male at birth. This decision reflects Wisp's commitment to advancing women’s health, improving access to treatment, and advocating for improved care outcomes. We will continue to monitor emerging data to ensure safe and effective treatment options.